메뉴 건너뛰기




Volumn 43, Issue 9, 2013, Pages 1039-1048

Adult-to-adult right-lobe living donor liver transplantation in high model for end-stage liver disease score recipients with hepatitis B virus-related benign liver diseases

Author keywords

Living donor liver transplantation; Model for end stage liver disease; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOSPORIN; LAMIVUDINE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

EID: 84882279118     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-013-0539-z     Document Type: Article
Times cited : (15)

References (24)
  • 1
    • 0036255697 scopus 로고    scopus 로고
    • Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: Too little, too late
    • 11965578 10.1053/jlts.2002.33194
    • Kam I. Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl. 2002;8:347-9.
    • (2002) Liver Transpl , vol.8 , pp. 347-349
    • Kam, I.1
  • 2
    • 0036249778 scopus 로고    scopus 로고
    • Right-liver living donor transplantation for decompensated end-stage liver disease
    • 11965577 10.1053/jlts.2002.32941
    • Testa G, Malagó M, Nadalin S, Hertl M, Lang H, Frilling A, et al. Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl. 2002;8:340-6.
    • (2002) Liver Transpl , vol.8 , pp. 340-346
    • Testa, G.1    Malagó, M.2    Nadalin, S.3    Hertl, M.4    Lang, H.5    Frilling, A.6
  • 3
  • 4
    • 34248634598 scopus 로고    scopus 로고
    • Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation
    • 17511683 10.1111/j.1600-6143.2007.01802.x 1:STN:280: DC%2BD2szgtFCgsw%3D%3D
    • Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007;7:1601-8.
    • (2007) Am J Transplant , vol.7 , pp. 1601-1608
    • Fisher, R.A.1    Kulik, L.M.2    Freise, C.E.3    Lok, A.S.4    Shearon, T.H.5    Brown, Jr.R.S.6
  • 5
    • 80053257252 scopus 로고    scopus 로고
    • Successful use of hepatitis B surface antigen-positive liver grafts in recipients with hepatitis B virus-related liver diseases
    • 21748846 10.1002/lt.22379
    • Jiang L, Yan L, Li B, Wen T, Zhao J, Jiang L, et al. Successful use of hepatitis B surface antigen-positive liver grafts in recipients with hepatitis B virus-related liver diseases. Liver Transpl. 2011;17:1236-8.
    • (2011) Liver Transpl , vol.17 , pp. 1236-1238
    • Jiang, L.1    Yan, L.2    Li, B.3    Wen, T.4    Zhao, J.5    Jiang, L.6
  • 6
    • 77954897950 scopus 로고    scopus 로고
    • Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin
    • 20659092 10.1111/j.1600-6143.2010.03208.x 1:CAS:528:DC%2BC3cXhtFahsbzF
    • Jiang L, Yan L, Li B, Wen T, Zhao J, Jiang L, et al. Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant. 2010;10:1861-9.
    • (2010) Am J Transplant , vol.10 , pp. 1861-1869
    • Jiang, L.1    Yan, L.2    Li, B.3    Wen, T.4    Zhao, J.5    Jiang, L.6
  • 7
    • 68949086783 scopus 로고    scopus 로고
    • The Clavien-Dindo classification of surgical complications: Five-year experience
    • 19638912 10.1097/SLA.0b013e3181b13ca2
    • Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-96.
    • (2009) Ann Surg , vol.250 , pp. 187-196
    • Clavien, P.A.1    Barkun, J.2    De Oliveira, M.L.3    Vauthey, J.N.4    Dindo, D.5    Schulick, R.D.6
  • 8
  • 9
    • 67649975639 scopus 로고    scopus 로고
    • Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft
    • 19399732 10.1002/lt.21606
    • Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, et al. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl. 2009;15:496-503.
    • (2009) Liver Transpl , vol.15 , pp. 496-503
    • Yi, N.J.1    Suh, K.S.2    Lee, H.W.3    Shin, W.Y.4    Kim, J.5    Kim, W.6
  • 11
    • 0037442204 scopus 로고    scopus 로고
    • Complications and long-term outcome of living liver donors: A survey of 1,508 cases in five Asian centers
    • 12589131 10.1097/01.TP.0000046534.45645.47
    • Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation. 2003;75:S12-5.
    • (2003) Transplantation , vol.75
    • Lo, C.M.1
  • 13
    • 3142638650 scopus 로고    scopus 로고
    • Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation
    • 15251354 10.1016/j.transproceed.2004.05.004 1:STN:280: DC%2BD2czkvFGnuw%3D%3D
    • Akyildiz M, Karasu Z, Arikan C, Kilic M, Zeytunlu M, Gunsar F, et al. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation. Transplant Proc. 2004;36:1442-4.
    • (2004) Transplant Proc. , vol.36 , pp. 1442-1444
    • Akyildiz, M.1    Karasu, Z.2    Arikan, C.3    Kilic, M.4    Zeytunlu, M.5    Gunsar, F.6
  • 14
    • 55949108827 scopus 로고    scopus 로고
    • Recipient morbidity after living and deceased donor liver transplantation: Findings from the A2ALL Retrospective Cohort Study
    • 18976306 10.1111/j.1600-6143.2008.02440.x 1:STN:280: DC%2BD1cjmsVSisg%3D%3D
    • Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008;8:2569-79.
    • (2008) Am J Transplant , vol.8 , pp. 2569-2579
    • Freise, C.E.1    Gillespie, B.W.2    Koffron, A.J.3    Lok, A.S.4    Pruett, T.L.5    Emond, J.C.6
  • 15
    • 24944586521 scopus 로고    scopus 로고
    • Outcomes of 385 adult-to-adult living donor liver transplant recipients: A report from the A2ALL Consortium
    • 16135918
    • Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242:314-23.
    • (2005) Ann Surg , vol.242 , pp. 314-323
    • Olthoff, K.M.1    Merion, R.M.2    Ghobrial, R.M.3    Abecassis, M.M.4    Fair, J.H.5    Fisher, R.A.6
  • 16
    • 6444230813 scopus 로고    scopus 로고
    • Evolving strategies to prevent HBV recurrence
    • 15382222 10.1002/lt.20258
    • Roche B, Samuel D. Evolving strategies to prevent HBV recurrence. Liver Transpl. 2004;10:S74-85.
    • (2004) Liver Transpl , vol.10
    • Roche, B.1    Samuel, D.2
  • 17
    • 20144389066 scopus 로고    scopus 로고
    • Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B
    • 15772792 10.1007/s00595-004-2919-x
    • Kubo S, Tanaka H, Shuto T, Takemura S, Yamamoto T, Kanazawa A, et al. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today. 2005;35:216-22.
    • (2005) Surg Today , vol.35 , pp. 216-222
    • Kubo, S.1    Tanaka, H.2    Shuto, T.3    Takemura, S.4    Yamamoto, T.5    Kanazawa, A.6
  • 18
    • 17344364991 scopus 로고    scopus 로고
    • Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
    • 9696028 10.1002/hep.510280241 1:STN:280:DyaK1czlvFWquw%3D%3D
    • Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology. 1998;28:585-9.
    • (1998) Hepatology , vol.28 , pp. 585-589
    • Markowitz, J.S.1    Martin, P.2    Conrad, A.J.3    Markmann, J.F.4    Seu, P.5    Yersiz, H.6
  • 19
    • 3042828511 scopus 로고    scopus 로고
    • Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease
    • 12029640 10.1053/jhep.2002.33681
    • Steinmüller T, Seehofer D, Rayes N, Müller AR, Settmacher U, Jonas S, et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology. 2002;35:1528-35.
    • (2002) Hepatology , vol.35 , pp. 1528-1535
    • Steinmüller, T.1    Seehofer, D.2    Rayes, N.3    Müller, A.R.4    Settmacher, U.5    Jonas, S.6
  • 20
    • 0034948689 scopus 로고    scopus 로고
    • Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis
    • 11451175 10.1016/S0168-8278(01)00080-0 1:CAS:528:DC%2BD3MXltlens7s%3D
    • Marzano A, Salizzoni M, Debernardi-Venon W, Smedile A, Franchello A, Ciancio A, et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol. 2001;34:903-10.
    • (2001) J Hepatol , vol.34 , pp. 903-910
    • Marzano, A.1    Salizzoni, M.2    Debernardi-Venon, W.3    Smedile, A.4    Franchello, A.5    Ciancio, A.6
  • 21
    • 33947304026 scopus 로고    scopus 로고
    • Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
    • 17383422 10.1053/j.gastro.2007.01.005 1:CAS:528:DC%2BD2sXkslCjurY%3D
    • Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology. 2007;132:931-7.
    • (2007) Gastroenterology , vol.132 , pp. 931-937
    • Gane, E.J.1    Angus, P.W.2    Strasser, S.3    Crawford, D.H.4    Ring, J.5    Jeffrey, G.P.6
  • 22
    • 33244474879 scopus 로고    scopus 로고
    • Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis
    • 16447195 10.1002/lt.20701
    • Zheng S, Chen Y, Liang T, Lu A, Wang W, Shen Y, et al. Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transpl. 2006;12:253-8.
    • (2006) Liver Transpl , vol.12 , pp. 253-258
    • Zheng, S.1    Chen, Y.2    Liang, T.3    Lu, A.4    Wang, W.5    Shen, Y.6
  • 23
    • 0035010523 scopus 로고    scopus 로고
    • Management of hepatitis B: 2000 - Summary of a workshop
    • 11375963 10.1053/gast.2001.24839 1:STN:280:DC%2BD3M3ps1Gnsw%3D%3D
    • Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology. 2001;120:1828-53.
    • (2001) Gastroenterology , vol.120 , pp. 1828-1853
    • Lok, A.S.1    Heathcote, E.J.2    Hoofnagle, J.H.3
  • 24
    • 0033833127 scopus 로고    scopus 로고
    • Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation
    • 10959482 10.1111/j.1432-2277.2000.tb01084.x 1:CAS:528: DC%2BD3cXmtlSlsb0%3D
    • Seehofer D, Rayes N, Berg T, Neuhaus R, Müller AR, Hopf U, et al. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation. Transpl Int. 2000;13:290-6.
    • (2000) Transpl Int , vol.13 , pp. 290-296
    • Seehofer, D.1    Rayes, N.2    Berg, T.3    Neuhaus, R.4    Müller, A.R.5    Hopf, U.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.